Real-Time BNB Signal Analytics
Generated Title: Pfizer's Metsera Mess: Another Pharma Giant Bites the Dust? Okay, so Pfizer's trying to buy Metsera, this obesity drug startup. Novo Nordisk is also in the mix, upping the ante with a $10 billion offer that dwarfs Pfizer's...
Pfizer's Second Act: Why Patience is the Only Prescription Pfizer. The name used to conjure images of scientific breakthroughs, a pipeline bursting with potential, and, let's be honest, a stock that seemed bulletproof. But lately? The narra...